JEFFREY WAYNE CORBETT
Nursing in Niantic, CT
License number
Pennsylvania TLRN035595
Category
Nursing
Type
Registered Nurse Temporary Permit
Address
Address
2
Niantic, CT 06357
Pennsylvania
Pennsylvania
Personal information
See more information about JEFFREY WAYNE CORBETT at radaris.comName
Address
Phone
5543 Ridge Ave #1R, Philadelphia, PA 19128
169 Sky Top Ter, Fairfield, CT 06825
1634 W Master St, Philadelphia, PA 19121
1634 W Master St APT 11, Philadelphia, PA 19121
152 Scott Rd, Terryville, CT 06786
Professional information
Pyrazolospiroketone Acetyl-Coa Carboxylase Inhibitors
US Patent:
8318762, Nov 27, 2012
Filed:
May 18, 2009
Appl. No.:
12/934375
Inventors:
Jeffrey W. Corbett - Niantic CT, US
Richard Elliott - Seattle WA, US
Kevin Freeman-Cook - Carlsbad CA, US
David A. Griffith - Old Saybrook CT, US
Dennis P. Phillion - St Charles MO, US
Richard Elliott - Seattle WA, US
Kevin Freeman-Cook - Carlsbad CA, US
David A. Griffith - Old Saybrook CT, US
Dennis P. Phillion - St Charles MO, US
Assignee:
Pfizer Inc. - New York NY
International Classification:
C07D 491/107, A61K 31/436, A61K 31/438
US Classification:
514278, 546 20
Abstract:
The invention provides compounds of Formula (1) or a pharmaceutically acceptable salt of said compound, wherein R, R, and Rare as described herein; pharmaceutical compositions thereof; and the use thereof in treating diseases, conditions or disorders modulated by the inhibition of acetyl-CoA carboxylase enzyme(s) in an animal.
Spiroketone Acetyl-Coa Carboxylase Inhibitors
US Patent:
2009027, Oct 29, 2009
Filed:
Nov 16, 2007
Appl. No.:
12/514596
Inventors:
Jeffrey Wayne Corbett - Niantic CT, US
Richard Louis Elliott - Seattle WA, US
Andrew Simon Bell - Kent, GB
Richard Louis Elliott - Seattle WA, US
Andrew Simon Bell - Kent, GB
International Classification:
A61K 31/438, C07D 491/107, A61P 3/04
US Classification:
514278, 546 17
Abstract:
The invention provides compounds of Formula (1) or a pharmaceutically acceptable salt of said compound, wherein R, R, R, R, R, R, R, Rand Rare as described herein; pharmaceutical compositions thereof; and the use thereof in treating mammals suffering from the condition of being overweight.
Substituted Indazole Amides And Their Use As Glucokinase Activators
US Patent:
2011031, Dec 29, 2011
Filed:
Mar 4, 2010
Appl. No.:
13/255329
Inventors:
Jeffrey W. Corbett - Niantic CT, US
Angel Guzman-Perez - Mystic CT, US
Jeffrey A. Pfefferkorn - Mystic CT, US
Meihua Tu - Mystic CT, US
Angel Guzman-Perez - Mystic CT, US
Jeffrey A. Pfefferkorn - Mystic CT, US
Meihua Tu - Mystic CT, US
International Classification:
A61K 31/497, C07D 403/14, A61K 31/506, A61K 31/4439, C07D 403/12, A61K 31/416, C07D 401/12, C07D 413/14, A61K 31/5377, C07D 417/12, A61K 31/433, A61K 31/4192, C07D 409/14, A61P 3/04, A61P 3/10, C07D 401/14
US Classification:
51421018, 544405, 51425505, 544295, 5462757, 514338, 5483611, 514407, 544120, 5142345, 548128, 514361, 548255
Abstract:
The present invention provides a compound of Formula (I) or a pharmaceutically acceptable salt thereof wherein R, R, R, X, Y and Z are as defined herein. The compounds of Formula (I) have been found to act as glucokinase activators. Consequently, the compounds of Formula (I) and the pharmaceutical compositions thereof are useful for the treatment of diseases, disorders, or conditions mediated by glucokinase.
4,4-Disubstituted-3,4-Dihydro-2 (1H)-Quinazoliniones Useful As Hiv Reverse Transcriptase Inhibitors
US Patent:
2004006, Apr 1, 2004
Filed:
Jul 31, 2003
Appl. No.:
10/632192
Inventors:
Jeffrey Corbett - Niantic CT, US
International Classification:
A61K031/517, C07D239/72
US Classification:
514/266300, 544/286000
Abstract:
The present invention relates to quinazolinone compounds of formula (I):
or stereoisomeric forms, stereoisomeric mixtures, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of HIV reverse transcriptase, and to pharmaceutical compositions and diagnostic kits comprising the same, and methods of using the same for treating viral infection or as an assay standard or reagent.
Substituted Pyrimidine Derivatives
US Patent:
2006021, Sep 28, 2006
Filed:
Jun 14, 2006
Appl. No.:
11/424073
Inventors:
Jeffrey Corbett - Niantic CT, US
Micheal Ennis - Chesterfield MO, US
Kristine Frank - Worcester MA, US
Jian-Min Fu - Burnaby, CA
Robert Hoffman - San Marcos CA, US
Patrick Verhoest - Old Lyme CT, US
Micheal Ennis - Chesterfield MO, US
Kristine Frank - Worcester MA, US
Jian-Min Fu - Burnaby, CA
Robert Hoffman - San Marcos CA, US
Patrick Verhoest - Old Lyme CT, US
International Classification:
A61K 31/506, A61K 31/4439
US Classification:
514256000, 544333000, 514340000, 546268100
Abstract:
This invention relates to compounds of Formula I,
a stereoisomer thereof, a pharmaceutically acceptable salt thereof, a prodrug thereof, or a pharmaceutically acceptable salt of a prodrug thereof. The compounds interact with CRFreceptors, including human CRFreceptors. This invention also relates to methods of using the compounds of the invention to treat a disorder or condition, the treatment of which can be effected or facilitated by antagonizing a CRF receptor, such as CNS disorders or diseases, particularly anxiety-related disorders such as anxiety, and mood disorders such as major depression.
Positive Allosteric Modulators Of The Nicotinic Acetylcholine Receptor
US Patent:
2005025, Nov 10, 2005
Filed:
Jul 1, 2005
Appl. No.:
11/174239
Inventors:
David Piotrowski - Waterford CT, US
Bruce Rogers - Mystic CT, US
William McWhorter - Parchment MI, US
Daniel Walker - Mystic CT, US
Jeffrey Corbett - Niantic CT, US
Vincent Groppi - Kalamazoo MI, US
Daniel Rudmann - Fishers IN, US
Bruce Rogers - Mystic CT, US
William McWhorter - Parchment MI, US
Daniel Walker - Mystic CT, US
Jeffrey Corbett - Niantic CT, US
Vincent Groppi - Kalamazoo MI, US
Daniel Rudmann - Fishers IN, US
International Classification:
C07D285/08, C07D277/04, C07D261/04
US Classification:
514344000, 514362000, 514378000, 514370000, 546289000, 548128000, 548190000, 548245000
Abstract:
The invention provides compounds of Formula I:
These compounds may be in the form of pharmaceutical salts or compositions, may be in pure enantiomeric form or racemic mixtures, and are useful in pharmaceuticals used to treat diseases or conditions in which α7 nAChR is known to be involved.
Substituted Pyrimidinones And Pyrimidinthiones
US Patent:
2005014, Jun 30, 2005
Filed:
Apr 20, 2004
Appl. No.:
10/827750
Inventors:
Jian-Min Fu - Burnaby, CA
Michael Ennis - Chesterfield MO, US
Robert Hoffman - San Marcos CA, US
Patrick Verhoest - Old Lyme CT, US
John Mickelson - Dexter MI, US
Jeffrey Corbett - Niantic CT, US
Michael Ennis - Chesterfield MO, US
Robert Hoffman - San Marcos CA, US
Patrick Verhoest - Old Lyme CT, US
John Mickelson - Dexter MI, US
Jeffrey Corbett - Niantic CT, US
International Classification:
A61K031/513, C07D043/04
US Classification:
514269000, 544319000
Abstract:
This invention relates to substituted pyrimidinone and pyrimidithione derivatives that bind with high affifnity to CRFreceptors, including human CRFreceptors. This invention also relates to methods of using the compounds of the invention to treat a disorder or condition, the treatment of which can be effected or facilitated by antagonizing a CRF receptor, such as CNS disorders or diseases, particularly anxiety disorders, and depression and stress related disorders.
Compounds As Crfreceptor Antagonists
US Patent:
7250418, Jul 31, 2007
Filed:
May 6, 2004
Appl. No.:
10/840485
Inventors:
Jeffrey W. Corbett - Niantic CT, US
Michael Dalton Ennis - Chesterfield MO, US
Kristine E. Frank - Worcester MA, US
Jian-Min Fu - Burnaby, CA
Robert Louis Hoffman - San Marcos CA, US
Patrick R. Verhoest - Old Lyme CT, US
Michael Dalton Ennis - Chesterfield MO, US
Kristine E. Frank - Worcester MA, US
Jian-Min Fu - Burnaby, CA
Robert Louis Hoffman - San Marcos CA, US
Patrick R. Verhoest - Old Lyme CT, US
Assignee:
Pfizer Inc - New York NY
International Classification:
A61K 31/4965, C07D 239/02, C07D 401/00, C07D 403/00, C07D 405/00
US Classification:
51425505, 544297, 544405
Abstract:
The present invention relates to compounds of Formula I,.
Substituted Pyrimidine Derivatives
US Patent:
7087617, Aug 8, 2006
Filed:
May 5, 2004
Appl. No.:
10/839055
Inventors:
Jeffrey W. Corbett - Niantic CT, US
Michael Dalton Ennis - Chesterfield MO, US
Kristine E. Frank - Worcester MA, US
Jian-Min Fu - Burnaby, CA
Robert Louis Hoffman - San Marcos CA, US
Patrick R. Verhoest - Old Lyme CT, US
Michael Dalton Ennis - Chesterfield MO, US
Kristine E. Frank - Worcester MA, US
Jian-Min Fu - Burnaby, CA
Robert Louis Hoffman - San Marcos CA, US
Patrick R. Verhoest - Old Lyme CT, US
Assignee:
Pfizer Inc. - New York NY
International Classification:
A61K 31/505, C07D 239/32
US Classification:
514275, 544297
Abstract:
This invention relates to compounds of Formula I,.
Substituted Aryl 1, 4-Pyrazine Derivatives
US Patent:
7041672, May 9, 2006
Filed:
May 12, 2004
Appl. No.:
10/844004
Inventors:
Patrick R. Verhoest - Old Lyme CT, US
Jeffrey W. Corbett - Niantic CT, US
Michael Dalton Ennis - Chesterfield MO, US
Kristine E. Frank - Worcester MA, US
Jian-Min Fu - Burnaby, CA
Robert Louis Hoffman - San Marcos CA, US
Jeffrey W. Corbett - Niantic CT, US
Michael Dalton Ennis - Chesterfield MO, US
Kristine E. Frank - Worcester MA, US
Jian-Min Fu - Burnaby, CA
Robert Louis Hoffman - San Marcos CA, US
Assignee:
Pfizer Inc. - New York NY
International Classification:
A61K 31/4965, C07D 401/00, C07D 403/00, C07D 405/00, C07D 409/00
US Classification:
51425505, 544405
Abstract:
Substituted aryl pyrazine derivatives of the formula I as defined herein,
and their use in treating anxiety disorders, depression and stress related disorders are disclosed.